Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

ABSTRACT: A phase II trial was launched to evaluate if neoadjuvant stereotactic ablative radiotherapy (SABR) before surgery improves oncologic outcomes in patients with stage I non-small cell lung cancer (NSCLC). We report a mandated interim safety analysis for the first 10 patients who completed pr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Radiat Oncol
Huvudupphovsmän: Palma, David A., Nguyen, Timothy K., Kwan, Keith, Gaede, Stewart, Landis, Mark, Malthaner, Richard, Fortin, Dalilah, Louie, Alexander V., Frechette, Eric, Rodrigues, George B., Yaremko, Brian, Yu, Edward, Dar, A. Rashid, Lee, Ting-Yim, Gratton, Al, Warner, Andrew, Ward, Aaron, Inculet, Richard
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2017
Ämnen:
Short Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://ncbi.nlm.nih.gov/pubmed/28129789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0770-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk